Edwards Lifesciences Corp.
This article was originally published in The Gray Sheet
Executive Summary
Baxter Healthcare's CardioVascular Group spin-off is being named after Miles "Lowell" Edwards, the founder of American Edwards Lab, which ultimately was acquired by Baxter in 1985. An electrical engineer by training, Edwards was the co-inventor of the first approved artificial heart valve. The tax-free deal, to be effected in the first six months of 2000, gives Baxter shareholders one share of the new company for each six shares of Baxter held. Edwards Lifesciences will be headquartered in Irvine, California, where the CardioVascular Group is based, and led by Baxter Group VP Michael Mussallem (1"The Gray Sheet" Jan. 10, p. 8)
You may also be interested in...
Baxter Web-Enabled Device Development Starting With Renal Dialysis
Baxter projects the growth rate of its renal business will accelerate to 15% "over the next several years" from its current growth rate of "10 to 12%" in part due to web-enabled devices under development.
Baxter Web-Enabled Device Development Starting With Renal Dialysis
Baxter projects the growth rate of its renal business will accelerate to 15% "over the next several years" from its current growth rate of "10 to 12%" in part due to web-enabled devices under development.
Baxter To Sell CVG's Products In Fringe International Markets After Spin-off
Baxter Healthcare will continue to distribute products produced by its Cardiovascular Group spin-off in several countries outside of the U.S., including Argentina, Australia, Greece, Ireland, New Zealand and certain Scandinavian countries, after CVG Controlled, Inc. becomes a separate entity in the first half of 2000.